SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-006017
Filing Date
2022-04-22
Accepted
2022-04-22 16:29:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A beam_2022_proxy_material.htm DEFA14A 35315
2 GRAPHIC img239614121_0.jpg GRAPHIC 108105
3 GRAPHIC img239614121_1.jpg GRAPHIC 83882
  Complete submission text file 0000950170-22-006017.txt   300932
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39208 | Film No.: 22845937
SIC: 2836 Biological Products, (No Diagnostic Substances)